Serina Therapeutics (SER) Preferred Shares (2025)

Serina Therapeutics (SER) posted Preferred Shares of $4.9 million for Q4 2025, little changed sequentially from $4.9 million in Q3 2025.

Serina Therapeutics (SER) Preferred Shares (2025) Analysis & Trends

Serina Therapeutics has reported Preferred Shares for 1 years, with the latest figure at $4.9 million in Q4 2025.

Quarterly Preferred Shares changed N/A year-over-year to $4.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.9 million (changed N/A YoY) and the FY2025 annual result came in at $4.9 million, changed N/A from the prior year.
Preferred Shares held at $4.9 million in Q4 2025 per SER's latest filing, from $4.9 million in the prior quarter.
Over five years, Preferred Shares peaked at $4.9 million in Q2 2025 and troughed at $4.9 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	139.69 Bn	131.84 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.54 Bn	78.54 Bn	3.93 Bn	-
3	Argenx Se	65.27 Bn	60.09 Bn	1.37 Bn	-
4	Moderna	59.41 Bn	54.27 Bn	52.00 Mn	-
5	BeOne Medicines	42.12 Bn	37.02 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.80 Bn	28.49 Bn	992.69 Mn	-
7	BioNTech SE	28.07 Bn	9.68 Bn	668.28 Mn	-
8	Insmed	27.55 Bn	26.39 Bn	358.27 Mn	-
9	Royalty Pharma	27.28 Bn	26.44 Bn	-	-
10	Serina Therapeutics	43.44 Mn	20.41 Mn	-	-

Download Data